Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Unionman Technology Co.,Ltd.
688609
5
Kingchem
301509
US Stock MarketDetailed Quotes
RNAZ Transcode Therapeutics
- 0.3621
- -0.0604-14.30%
Close May 6 16:00 ET
- 0.3599
- -0.0022-0.61%
Post 17:11 ET
8.45MMarket Cap-0.01P/E (TTM)
0.4100High0.3521Low2.19MVolume0.4090Open0.4225Pre Close823.47KTurnover9.42%Turnover RatioLossP/E (Static)23.34MShares65.670052wk High-4.21P/B8.44MFloat Cap0.219652wk Low--Dividend TTM23.31MShs Float184800.0000Historical High--Div YieldTTM13.70%Amplitude0.2196Historical Low0.3750Avg Price1Lot Size
Transcode Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 109.97%5.81M | 109.97%5.81M | -74.83%1.88M | -6.10%3.35M | 202.82%4.91M | -44.30%2.77M | -44.30%2.77M | -15.22%7.45M | -73.42%3.57M | -90.37%1.62M |
| -Cash and cash equivalents | 109.97%5.81M | 109.97%5.81M | -74.83%1.88M | -6.10%3.35M | 202.82%4.91M | -44.30%2.77M | -44.30%2.77M | -15.22%7.45M | -73.42%3.57M | -90.37%1.62M |
| Receivables | ---- | ---- | --11.95K | ---- | ---- | ---- | ---- | --0 | --0 | --0 |
| -Other receivables | ---- | ---- | --11.95K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Prepaid assets | -15.78%454.06K | -15.78%454.06K | -28.23%474.45K | -10.96%499.41K | -8.35%519.82K | -2.75%539.1K | -2.75%539.1K | 263.12%661.11K | 266.30%560.91K | 456.42%567.19K |
| Other current assets | -27.90%828.22K | -27.90%828.22K | -0.72%1.25M | -29.90%532.46K | -40.63%1.28M | -23.23%1.15M | -23.23%1.15M | -40.30%1.26M | 130.68%759.56K | 28.37%2.16M |
| Total current assets | 59.21%7.09M | 59.21%7.09M | -61.46%3.61M | -10.35%4.39M | 54.47%6.71M | -39.62%4.46M | -39.62%4.46M | -18.98%9.37M | -64.85%4.89M | -76.67%4.35M |
| Non current assets | ||||||||||
| Net PPE | -85.18%89.31K | -85.18%89.31K | -71.50%211.66K | -62.78%326.31K | -53.37%464.59K | 188.81%602.4K | 188.81%602.4K | 253.82%742.57K | 273.61%876.75K | 362.67%996.23K |
| -Gross PPE | -53.78%400.12K | -53.78%400.12K | -42.98%555.55K | -39.27%654.17K | -34.80%760.1K | 148.46%865.74K | 148.46%865.74K | 204.24%974.26K | 236.39%1.08M | 319.06%1.17M |
| -Accumulated depreciation | -18.03%-310.81K | -18.03%-310.81K | -48.43%-343.89K | -63.55%-327.86K | -74.34%-295.51K | -88.29%-263.34K | -88.29%-263.34K | -109.95%-231.69K | -134.32%-200.47K | -169.67%-169.5K |
| Non current deferred assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --135.8K |
| Non current prepaid assets | 0.00%111.86K | 0.00%111.86K | 0.00%111.86K | 0.00%111.86K | 0.00%111.86K | --111.86K | --111.86K | --111.86K | --111.86K | --111.86K |
| Total non current assets | -71.84%201.16K | -71.84%201.16K | -62.14%323.52K | -55.68%438.17K | -53.66%576.45K | 242.44%714.26K | 242.44%714.26K | 91.71%854.43K | 321.27%988.61K | 477.68%1.24M |
| Total assets | 41.10%7.29M | 41.10%7.29M | -61.52%3.94M | -17.97%4.82M | 30.41%7.29M | -31.87%5.17M | -31.87%5.17M | -14.88%10.23M | -58.45%5.88M | -70.34%5.59M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current accrued expenses | -11.25%2.71M | -11.25%2.71M | -58.52%2.13M | 7.59%3.28M | -53.22%2.37M | -29.81%3.05M | -29.81%3.05M | 37.12%5.14M | 78.67%3.04M | 177.11%5.06M |
| Current debt and capital lease obligation | -90.71%38.29K | -90.71%38.29K | -62.34%152.48K | -42.85%227.25K | -13.07%339.41K | --412.28K | --412.28K | --404.93K | --397.64K | --390.42K |
| -Current capital lease obligation | -90.71%38.29K | -90.71%38.29K | -62.34%152.48K | -42.85%227.25K | -13.07%339.41K | --412.28K | --412.28K | --404.93K | --397.64K | --390.42K |
| Current deferred liabilities | -6.09%25.41K | -6.09%25.41K | --0 | --0 | --0 | --27.06K | --27.06K | 130.72%54.31K | 247.30%81.75K | ---- |
| Current liabilities | -20.59%2.77M | -20.59%2.77M | -59.20%2.28M | -0.60%3.5M | -50.34%2.71M | -19.71%3.49M | -19.71%3.49M | 48.44%5.6M | 103.99%3.52M | 194.70%5.45M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | --0 | --0 | --0 | --0 | --0 | --38.29K | --38.29K | --189.77K | --265.65K | --377.81K |
| -Long term capital lease obligation | --0 | --0 | --0 | --0 | --0 | --38.29K | --38.29K | --189.77K | --265.65K | --377.81K |
| Derivative product liabilities | --6.54M | --6.54M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Total non current liabilities | 16,983.38%6.54M | 16,983.38%6.54M | --0 | --0 | --0 | --38.29K | --38.29K | --189.77K | --265.65K | --377.81K |
| Total liabilities | 163.91%9.31M | 163.91%9.31M | -60.54%2.28M | -7.57%3.5M | -53.56%2.71M | -18.83%3.53M | -18.83%3.53M | 53.47%5.79M | 119.37%3.79M | 215.13%5.83M |
| Shareholders'equity | ||||||||||
| Share capital | 5,050.00%103 | 5,050.00%103 | 61.55%1.73K | 272.82%727 | -63.27%581 | 0.00%2 | 0.00%2 | -17.64%1.07K | -84.98%195 | 21.88%1.58K |
| -common stock | 5,050.00%103 | 5,050.00%103 | 61.55%1.73K | 272.82%727 | -63.27%581 | 0.00%2 | 0.00%2 | -17.64%1.07K | -84.98%195 | 21.88%1.58K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -36.16%-63.2M | -36.16%-63.2M | -35.26%-57.26M | -48.35%-54.93M | -52.18%-49.74M | -66.54%-46.42M | -66.54%-46.42M | -86.17%-42.33M | -100.74%-37.03M | -137.29%-32.69M |
| Paid-in capital | 27.31%61.18M | 27.31%61.18M | 25.95%58.91M | 43.80%56.26M | 67.42%54.33M | 54.47%48.06M | 54.47%48.06M | 50.97%46.77M | 26.71%39.12M | 5.44%32.45M |
| Total stockholders'equity | -223.03%-2.02M | -223.03%-2.02M | -62.79%1.65M | -36.81%1.32M | 2,036.00%4.58M | -49.37%1.64M | -49.37%1.64M | -46.15%4.44M | -83.16%2.09M | -101.39%-236.79K |
| Total equity | -223.03%-2.02M | -223.03%-2.02M | -62.79%1.65M | -36.81%1.32M | 2,036.00%4.58M | -49.37%1.64M | -49.37%1.64M | -46.15%4.44M | -83.16%2.09M | -101.39%-236.79K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
